Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization

Conditions:   Lung Transplant Rejection;   Antibody-mediated Rejection Interventions:   Drug: Belatacept;   Drug: Carfilzomib Sponsors:   Duke University;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials